Literature DB >> 22005935

Dengue-associated transient muscle dysfunction: clinical, electromyography and histopathological changes.

U K Misra1, J Kalita, P K Maurya, P Kumar, S K Shankar, A Mahadevan.   

Abstract

BACKGROUND: Dengue is commonly associated with myalgia, but there is paucity of studies on the frequency, severity, and basis of muscle involvement. The aim of this study was to document the clinical, electromyographic, and histological changes in dengue-associated muscle dysfunction.
MATERIALS AND METHODS: Seropositive dengue patients admitted to the neurology ward during 2010 were enrolled in this study. Detailed medical history, including bleeding diathesis and organomegaly, were noted. Muscle power on a 0-5 scale, muscle tone, reflex, sensations and coordination were tested. Blood counts, hemoglobin, and serum chemistry, including creatine kinase (CK) evaluations, were carried out. Concentric needle electromyography (EMG) and muscle biopsy were performed when clinical conditions were suitable.
RESULTS: The study cohort comprised 39 patients with dengue, with a median age of 28 years. Of these, 31 patients showed evidence of muscle involvement-16 with clinical and 15 with subclinical muscle involvement. Eight of these patients had severe weakness and five had hyporeflexia. Thrombocytopenia was present in 26 patients, elevated serum creatinine in three patients and liver dysfunction in 31 patients. The median CK level was 837 (range 194-3,832) U/L. The EMG revealed polyphasic normal to short duration motor unit potentials, but spontaneous activity was absent. Muscle biopsy in three patients revealed interstitial hemorrhage with occasional necrosis and myophagocytosis. There was no vasculitis, but subtle inflammatory changes were present in one patient. The severity of muscle weakness correlated with the platelet count and CK level. All patients improved by 15 days of treatment initiation.
CONCLUSION: Dengue commonly results in benign and self-limiting transient muscle dysfunction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005935     DOI: 10.1007/s15010-011-0203-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Clinical manifestations of dengue and leptospirosis in children in Mumbai: an observational study.

Authors:  S A Zaki; P Shanbag
Journal:  Infection       Date:  2010-05-27       Impact factor: 3.553

2.  The burden of dengue infection.

Authors:  Scott B Halstead; Jose A Suaya; Donald S Shepard
Journal:  Lancet       Date:  2007-04-28       Impact factor: 79.321

3.  Severe, persisting, steroid-responsive Dengue myositis.

Authors:  Josef Finsterer; Kittipong Kongchan
Journal:  J Clin Virol       Date:  2006-01-18       Impact factor: 3.168

4.  Host defence mechanisms against dengue virus infection of mice.

Authors:  U C Chaturvedi; P Tandon; A Mathur; A Kumar
Journal:  J Gen Virol       Date:  1978-05       Impact factor: 3.891

5.  Neurological manifestations of dengue infection.

Authors:  T Solomon; N M Dung; D W Vaughn; R Kneen; L T Thao; B Raengsakulrach; H T Loan; N P Day; J Farrar; K S Myint; M J Warrell; W S James; A Nisalak; N J White
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  Dengue. Muscle biopsy findings in 15 patients.

Authors:  S M Malheiros; A S Oliveira; B Schmidt; J G Lima; A A Gabbai
Journal:  Arq Neuropsiquiatr       Date:  1993-06       Impact factor: 1.420

7.  Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever.

Authors:  B V Cam; L Fonsmark; N B Hue; N T Phuong; A Poulsen; E D Heegaard
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

8.  Acute pure motor quadriplegia: is it dengue myositis?

Authors:  J Kalita; U K Misra; A Mahadevan; S K Shankar
Journal:  Electromyogr Clin Neurophysiol       Date:  2005 Sep-Oct

9.  Neurological manifestations of dengue virus infection.

Authors:  U K Misra; J Kalita; U K Syam; T N Dhole
Journal:  J Neurol Sci       Date:  2006-03-09       Impact factor: 3.181

10.  Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells.

Authors:  Rajas V Warke; Aniuska Becerra; Agatha Zawadzka; Diane J Schmidt; Katherine J Martin; Kris Giaya; Jonathan H Dinsmore; Marcia Woda; Gregory Hendricks; Tracy Levine; Alan L Rothman; Irene Bosch
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

View more
  17 in total

1.  Infections are a global issue: infection addresses global issues.

Authors:  M P Grobusch; G Calleri; J R Bogner
Journal:  Infection       Date:  2012-12       Impact factor: 3.553

Review 2.  Beyond thrombocytopaenia, haemorrhage and shock: the expanded dengue syndrome.

Authors:  Senaka Rajapakse; Milanka Wattegama; Praveen Weeratunga; P Chathurani Sigera; Sumadhya Deepika Fernando
Journal:  Pathog Glob Health       Date:  2018-12-03       Impact factor: 2.894

Review 3.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014

4.  Evaluation of creatine kinase and liver enzymes in identification of severe dengue.

Authors:  Saiful Safuan Md Sani; Winn Hui Han; Mohamad Adam Bujang; Hui Jen Ding; Kiah Loon Ng; Mohd Azizuddin Amir Shariffuddin
Journal:  BMC Infect Dis       Date:  2017-07-21       Impact factor: 3.090

5.  Yellow Fever and Traveling Athletes: Is Competing in Brazil Safe?

Authors:  Rodrigo Luiz Vancini; Marília Santos Andrade; Cássia Regina Vancini-Campanharo; Claudio Andre Barbosa de Lira
Journal:  J Hum Kinet       Date:  2017-06-22       Impact factor: 2.193

6.  Dengue-associated acute kidney injury.

Authors:  João Fernando Picollo Oliveira; Emmanuel A Burdmann
Journal:  Clin Kidney J       Date:  2015-10-16

Review 7.  Can non-human primates serve as models for investigating dengue disease pathogenesis?

Authors:  Kristina B Clark; Nattawat Onlamoon; Hui-Mien Hsiao; Guey C Perng; Francois Villinger
Journal:  Front Microbiol       Date:  2013-10-11       Impact factor: 5.640

8.  Risk factors for fatality among confirmed adult dengue inpatients in Singapore: a matched case-control study.

Authors:  Tun-Linn Thein; Yee-Sin Leo; Dale A Fisher; Jenny G Low; Helen M L Oh; Victor C Gan; Joshua G X Wong; David C Lye
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

Review 9.  Biopsy proven acute tubular necrosis due to rhabdomyolysis in a dengue fever patient: a case report and review of literature.

Authors:  Liliany P Repizo; Denise M Malheiros; Luis Yu; Rui T Barros; Emmanuel A Burdmann
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

Review 10.  Neurological Manifestations of Dengue Infection.

Authors:  Guo-Hong Li; Zhi-Jie Ning; Yi-Ming Liu; Xiao-Hong Li
Journal:  Front Cell Infect Microbiol       Date:  2017-10-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.